Showing results (21-30 of 451) with videos related to
Sort By:
Pageof 46
Archives of Internal Medicine|July 11, 2007
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older menRobert Clarke, Jonathan R Emberson, Sarah Parish, et al.Current Opinion in Lipidology|July 13, 2006
Statins: are any questions unanswered?Patricia M Kearney, Colin BaigentNature Reviews. Cardiology|February 29, 2012
Prevention. Aspirin in primary prevention--good news and bad newsCharles H Hennekens, Colin BaigentEclinicalmedicine|November 12, 2021
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trialsNatalie Staplin, Alistair J Roddick, Jonathan Emberson, et al.Kidney International Reports|August 4, 2023
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)William G Herrington, Charlie Harper, Natalie Staplin, et al.Vascular Health and Risk Management|March 1, 2007
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?Jonathan R Emberson, Derrick A BennettHeart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.Current Opinion in Nephrology and Hypertension|October 16, 2004
Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trialsColin Baigent, Martin Landray, Marion WarrenKidney International Reports|June 2, 2018
Impact of CKD on Household IncomeRachael L Morton, Iryna Schlackow, Alastair Gray, et al.Pageof 46